• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

游离壳聚糖在骨创伤和骨癌治疗中的潜在作用。

The potential role of free chitosan in bone trauma and bone cancer management.

机构信息

Department of Orthopaedics, St Vincent's Health, University of Melbourne, Fitzroy 3065, Australia.

Department of Orthopaedics, the First Affiliated Hospital with Nanjing Medical University, Nanjing 210029, China.

出版信息

Biomaterials. 2014 Sep;35(27):7828-38. doi: 10.1016/j.biomaterials.2014.05.087. Epub 2014 Jun 17.

DOI:10.1016/j.biomaterials.2014.05.087
PMID:24947230
Abstract

Bone defects caused by fractures or cancer-mediated destruction are debilitating. Chitosan is commonly used in scaffold matrices for bone healing, but rarely as a free drug. We demonstrate that free chitosan promotes osteoblast proliferation and osteogenesis in mesenchymal stem cells, increases osteopontin and collagen I expression, and reduces osteoclastogenesis. Chitosan inhibits invasion of endothelial cells, downregulating uPA/R, MT1-MMP, cdc42 and Rac1. Better healing of bone fractures with greater trabecular bone formation was observed in mice treated with chitosan. Chitosan induces apoptosis in osteotropic prostate and breast cancer cells via caspase-2 and -3 activation, and reduces their establishment in bone. Chitosan is pro-apoptotic in osteosarcoma cells, but not their normal counterpart, osteoblasts, or chondrosarcoma cells. Systemic delivery of chitosan does not perturb angiogenesis, bone volume or instinctive behaviour in pregnant mice, but decreases foetal length and changes pancreatic secretory acini. With certain controls in place, chitosan could be useful for bone trauma management.

摘要

由骨折或癌症介导的破坏引起的骨缺损是使人衰弱的。壳聚糖常用于骨愈合的支架基质,但很少作为游离药物使用。我们证明游离壳聚糖可促进间充质干细胞中成骨细胞的增殖和骨生成,增加骨桥蛋白和胶原 I 的表达,并减少破骨细胞的生成。壳聚糖抑制内皮细胞的侵袭,下调 uPA/R、MT1-MMP、cdc42 和 Rac1。用壳聚糖处理的小鼠观察到骨折愈合更好,小梁骨形成更多。壳聚糖通过半胱天冬酶-2 和 -3 的激活诱导亲骨性前列腺癌和乳腺癌细胞凋亡,并减少其在骨中的定植。壳聚糖对骨肉瘤细胞具有促凋亡作用,但对其正常对应物成骨细胞或软骨肉瘤细胞没有作用。壳聚糖在怀孕小鼠中全身给药不会干扰血管生成、骨量或本能行为,但会降低胎儿长度并改变胰腺分泌的腺泡。在采取某些控制措施的情况下,壳聚糖可用于管理骨创伤。

相似文献

1
The potential role of free chitosan in bone trauma and bone cancer management.游离壳聚糖在骨创伤和骨癌治疗中的潜在作用。
Biomaterials. 2014 Sep;35(27):7828-38. doi: 10.1016/j.biomaterials.2014.05.087. Epub 2014 Jun 17.
2
The beneficial effect of icaritin on osteoporotic bone is dependent on the treatment initiation timing in adult ovariectomized rats.朝藿定 C 对去卵巢大鼠骨质疏松性骨的有益作用取决于成年大鼠去卵巢时的治疗起始时间。
Bone. 2013 Jul;55(1):230-40. doi: 10.1016/j.bone.2013.02.012. Epub 2013 Feb 26.
3
Prostate-specific antigen induces apoptosis of osteoclast precursors: potential role in osteoblastic bone metastases of prostate cancer.前列腺特异性抗原诱导破骨细胞前体细胞凋亡:在前列腺癌成骨性骨转移中的潜在作用。
Prostate. 2006 Nov 1;66(15):1573-84. doi: 10.1002/pros.20375.
4
A novel flavonoid C-glucoside from Ulmus wallichiana preserves bone mineral density, microarchitecture and biomechanical properties in the presence of glucocorticoid by promoting osteoblast survival: a comparative study with human parathyroid hormone.从榆属植物中分离得到的一种新型黄酮 C-糖苷通过促进成骨细胞存活来维持糖皮质激素存在下的骨密度、微结构和生物力学特性:与人甲状旁腺激素的比较研究。
Phytomedicine. 2013 Nov 15;20(14):1256-66. doi: 10.1016/j.phymed.2013.07.007. Epub 2013 Aug 6.
5
Gefitinib inhibits the cross-talk between mesenchymal stem cells and prostate cancer cells leading to tumor cell proliferation and inhibition of docetaxel activity.吉非替尼抑制间充质干细胞和前列腺癌细胞之间的串扰,导致肿瘤细胞增殖和多西他赛活性抑制。
J Cell Biochem. 2013 May;114(5):1135-44. doi: 10.1002/jcb.24456.
6
The natural flavonoid galangin inhibits osteoclastic bone destruction and osteoclastogenesis by suppressing NF-κB in collagen-induced arthritis and bone marrow-derived macrophages.天然类黄酮高良姜素通过抑制胶原诱导性关节炎和骨髓来源巨噬细胞中的 NF-κB 抑制破骨细胞性骨破坏和破骨细胞生成。
Eur J Pharmacol. 2013 Jan 5;698(1-3):57-66. doi: 10.1016/j.ejphar.2012.08.013. Epub 2012 Sep 14.
7
Bone environment is essential for osteosarcoma development from transformed mesenchymal stem cells.骨环境对于转化的间充质干细胞发展成骨肉瘤至关重要。
Stem Cells. 2014 May;32(5):1136-48. doi: 10.1002/stem.1647.
8
Injectable calcium phosphate-alginate-chitosan microencapsulated MC3T3-E1 cell paste for bone tissue engineering in vivo.可注射的磷酸钙-藻酸盐-壳聚糖微囊化 MC3T3-E1 细胞糊剂用于体内骨组织工程。
Mater Sci Eng C Mater Biol Appl. 2013 Dec 1;33(8):4633-9. doi: 10.1016/j.msec.2013.07.022. Epub 2013 Jul 24.
9
Imatinib promotes osteoblast differentiation by inhibiting PDGFR signaling and inhibits osteoclastogenesis by both direct and stromal cell-dependent mechanisms.伊马替尼通过抑制血小板衍生生长因子受体(PDGFR)信号传导促进成骨细胞分化,并通过直接和基质细胞依赖机制抑制破骨细胞生成。
J Bone Miner Res. 2007 Nov;22(11):1679-89. doi: 10.1359/jbmr.070719.
10
Proline/arginine-rich end leucine-rich repeat protein N-terminus is a novel osteoclast antagonist that counteracts bone loss.脯氨酸/精氨酸丰富的末端亮氨酸丰富的重复蛋白 N 端是一种新型的破骨细胞拮抗剂,可对抗骨质流失。
J Bone Miner Res. 2013 Sep;28(9):1912-24. doi: 10.1002/jbmr.1951.

引用本文的文献

1
Recent advances in hydrogel-assisted treatment of malignant bone tumors.水凝胶辅助治疗恶性骨肿瘤的最新进展
Mater Today Bio. 2025 Jul 14;33:102088. doi: 10.1016/j.mtbio.2025.102088. eCollection 2025 Aug.
2
Biomaterial Cues for Regulation of Osteoclast Differentiation and Function in Bone Regeneration.用于调节骨再生中破骨细胞分化和功能的生物材料线索
Adv Ther (Weinh). 2025 Jan;8(1). doi: 10.1002/adtp.202400296. Epub 2024 Nov 15.
3
Nanoparticles and bone microenvironment: a comprehensive review for malignant bone tumor diagnosis and treatment.
纳米颗粒与骨微环境:恶性骨肿瘤诊治的全面综述
Mol Cancer. 2024 Nov 1;23(1):246. doi: 10.1186/s12943-024-02161-1.
4
Zinc and chitosan-enhanced β-tricalcium phosphate from calcined fetal bovine bone for mandible reconstruction.锌和壳聚糖增强的煅烧胎牛骨β-磷酸三钙用于下颌骨重建。
Front Bioeng Biotechnol. 2024 Sep 27;12:1355493. doi: 10.3389/fbioe.2024.1355493. eCollection 2024.
5
Bifunctional bone substitute materials for bone defect treatment after bone tumor resection.用于骨肿瘤切除术后骨缺损治疗的双功能骨替代材料。
Mater Today Bio. 2023 Dec 1;23:100889. doi: 10.1016/j.mtbio.2023.100889. eCollection 2023 Dec.
6
Pigment Epithelium-Derived Factor: Inhibition of Phosphorylation of Insulin Receptor (IR)/IR Substrate (IRS), Osteogeneration from Adipocytes, and Increased Levels Due to Doxorubicin Exposure.色素上皮衍生因子:对胰岛素受体(IR)/胰岛素受体底物(IRS)磷酸化的抑制作用、脂肪细胞的成骨作用以及多柔比星暴露导致的水平升高
Pharmaceutics. 2023 Jul 15;15(7):1960. doi: 10.3390/pharmaceutics15071960.
7
The emerging role of cancer nanotechnology in the panorama of sarcoma.癌症纳米技术在肉瘤领域中日益凸显的作用。
Front Bioeng Biotechnol. 2022 Oct 17;10:953555. doi: 10.3389/fbioe.2022.953555. eCollection 2022.
8
Patient-derived cancer models: Valuable platforms for anticancer drug testing.患者来源的癌症模型:抗癌药物测试的宝贵平台。
Front Oncol. 2022 Aug 12;12:976065. doi: 10.3389/fonc.2022.976065. eCollection 2022.
9
Chitosan Nanoparticles in Atherosclerosis-Development to Preclinical Testing.壳聚糖纳米颗粒在动脉粥样硬化中的研究:从发病机制到临床前测试
Pharmaceutics. 2022 Apr 25;14(5):935. doi: 10.3390/pharmaceutics14050935.
10
Mineralization in a Critical Size Bone-Gap in Sheep Tibia Improved by a Chitosan-Calcium Phosphate-Based Composite as Compared to Predicate Device.与对照装置相比,基于壳聚糖-磷酸钙的复合材料改善了绵羊胫骨临界尺寸骨缺损中的矿化情况。
Materials (Basel). 2022 Jan 22;15(3):838. doi: 10.3390/ma15030838.